Distinguishing the progression of an endometrioma: Benign or malignant?

BAŞTU E., Onder S., Demiral I., Ozsurmeli M., Keskin G., TAKMAZ Ö., ...More

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, vol.230, pp.79-84, 2018 (SCI-Expanded) identifier identifier identifier


Objective: To elucidate the immunohistochemical (IHC) differences of endometrioma tissues that may have the potential to progress to ovarian clear cell carcinoma (OCCC) by using KRAS, HNF1 beta, PIK3CA, PPP2R1A, and ARID1A as biomarkers.